N-acetylcysteine (intravenous)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for N-acetylcysteine (intravenous), covering 2019-02-19 to 2023-01-05. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions [Phase 3]